Author:
Besselaar Terry G.,Naidoo Dhamari,Buys Amelia,Gregory Vicky,McAnerney Jo,Manamela Jack M.,Blumberg Lucille,Schoub Barry D.
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference8 articles.
1. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.;Kim;J Am Chem Soc,1997
2. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Eurosurveillance. 2008;13 [cited 2008 Jul 11]. Available from http://www.eurosurveillance.org/edition/v13n05/080131_2.asp
3. Influenza A. (H1N1) virus resistance to oseltamivir: last quarter 2007 to first quarter 2008. 2008 Jun 13 [cited 2008 Jul 11]. Available from http://www.who.int/csr/disease/influenza/oseltamivir_summary/en/index.html
4. Impact of the introduction of A/Sydney/5/97 H3N2 influenza virus into South Africa.;Besselaar;J Med Virol,1999
5. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.;Wetherall;J Clin Microbiol,2003
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献